Lululemon Stock Alert: Why Analysts Are Hitting the Pause Button
Lululemon stock was downgraded. Analysts think competition is too tough and future profit predictions are "too high," creating financial risk.
Lululemon stock was downgraded. Analysts think competition is too tough and future profit predictions are "too high," creating financial risk.
New pancreatic cancer drug (atebimetinib + chemo) shows "extraordinary" results: 86% overall survival (OS) at 9 months, far exceeding the 47% standard of care. Pivotal trials planned for late 2025.
Intel Corp., backed by the US government, is seeking further investment, approaching Apple for a deal that would validate the ailing chipmaker's crucial domestic turnaround efforts, even as challenges persist.
Lantheus licenses PYLARIFY, a leading PSMA PET imaging agent for prostate cancer, exclusively to GE HealthCare for development, manufacturing, and sales in Japan, a key international market.
A deadly mud rush halted production at Grasberg, the world's 2nd largest copper mine. Freeport declared force majeure, causing copper prices to spike sharply. Two workers died; five are missing. Major supply delays are now expected until 2027.
Novacap is buying digital ad quality firm Integral Ad Science (IAS) for $1.9 billion. The deal pays $10.30 per share in cash, a 22% premium. IAS will use the funds to invest in AI technology and growth. It will become a privately held company soon.